<DOC>
	<DOCNO>NCT02096926</DOCNO>
	<brief_summary>This single center placebo control , prospective , randomize study healthy adult undergoing third molar surgery .</brief_summary>
	<brief_title>Methodological Validation Ibuprofen Verses Placebo Post Operative Pain After Third Molar Extraction Surgery</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Toothache</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Patients provide write informed consent prior enrollment Male female 18 40 year age Patients schedule undergo elective ipsilateral two ( 2 ) third molar extraction surgery local anesthesia The mandibular third molar must involve full partial bony impaction confirm radiographic evidence Female subject eligible follow apply Not pregnant ( subject child bear potential must negative urine beta human chorionic gonadotropin ( Î²hCG ) pregnancy test surgery ) Not lactate Not plan become pregnant within duration study Patients willing capable understanding cooperating requirement study Patients able understand communicate English Patients participate Lotus Clinical Research placebo response pain scale education train program Patients medical condition , Investigator 's opinion , could adversely impact patient 's participation , safety , conduct study limit history severe renal hepatic impairment , severe active hepatic disease , acute chronic pain condition , clinically significant medical condition Patients know history intolerance , severe allergy hypersensitivity Ibuprofen , opioid analgesic , Lidocaine , acetaminophen ( APAP ) Patients abused prescription medication alcohol within two year start study Patients surgical complication could compromise safety subject confound result study The subject take corticosteroid chronically ( except inhale steroid pulmonary disease ) take systemic corticosteroid within 4 week propose date surgery The subject take central nervous system ( CNS ) active drug benzodiazepine , tricyclic antidepressant , selective serotonin reuptake inhibitor ( SSRIs ) serotonin norepinephrine reuptake inhibitor ( SNRIs ) pain . These drug permit nonpain indication throughout study , dose stable least 30 day The subject use acetylsalicylic acid , acetaminophen nonsteroidal antiinflammatory drug ( NSAIDs ) within 5 halflives prior plan day surgery The subject take antihypertensive agent ( ) diabetic regimen dose stable least 28 day . Patients history seizure , currently take anticonvulsant Patients dysphagia and/or swallow study medication whole Patient unable adequately communicate study staff , properly give informed consent , otherwise comply study procedure Patient participate another clinical trial investigational drug device within 30 day screen visit schedule receive investigational product participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Third Molar Extraction</keyword>
</DOC>